Brooke Lianne Gates
| Title | Post-Doctoral Fellow |
|---|
| Institution | University of Colorado Denver - Anschutz Medical Campus |
|---|
| Department | SOM-PHARM General Operations |
|---|
|
|
|
Bibliographic
-
Andrews HS, Bado IL, Beumer A, Chan IS, Cowden J, Denardi D, Echeverria GV, Gates BL, Gilliam M, Hodgdon C, Lee AV, Mancuso J, Maues J, Oesterreich S, Papanicolaou M, Pendleton KE, Riter B, Shanahan K, Tran-Huynh AM, Viswanath P, Walker S, Welm AL, Williams MM, Wyatt GL, Newby J. The MBCRC Advocate Researcher Program (MARP): connecting advocates and researchers as collaborative partners in cancer research. NPJ Breast Cancer. 2025 Jun 21; 11(1):60. PMID: 40544177.
-
Rodrigues Sousa E, de Brot S, Zoni E, Zeinali S, Brunello A, Scarpa M, De Menna M, La Manna F, Abey Alexander A, Klima I, Freeman DW, Gates BL, Cristaldi DA, Guenat OT, Kruithof BPT, Spike BT, Chouvardas P, Kruithof-de Julio M. CRIPTO's multifaceted role in driving aggressive prostate cancer unveiled by in vivo, organoid, and patient data. Oncogene. 2025 Mar; 44(7):462-475. PMID: 39592836.
-
Balcioglu O, Gates BL, Freeman DW, Hagos BM, Mehrabad EM, Ayala-Talavera D, Spike BT. Mcam stabilizes a luminal progenitor-like breast cancer cell state via Ck2 control and Src/Akt/Stat3 attenuation. NPJ Breast Cancer. 2024 Sep 14; 10(1):80. PMID: 39277578.
-
Freeman DW, Gates BL, Spendlove MD, Gulbahce HE, Spike BT. CRIPTO promotes extracellular vesicle uptake and activation of cancer associated fibroblasts. bioRxiv. 2024 Apr 02. PMID: 38496478.
-
Balcioglu O, Gates BL, Freeman DW, Hagos BM, Mehrabad EM, Ayala-Talavera D, Spike BT. Mcam stabilizes luminal progenitor breast cancer phenotypes via Ck2 control and Src/Akt/Stat3 attenuation. bioRxiv. 2024 Mar 20. PMID: 38562809.
-
Fukuto A, Kang J, Gates BL, Sannajust K, Pinkerton KE, Van Winkle LS, Kiuchi Y, Leonard BC, Thomasy SM. Effect of graphene-based nanomaterials on corneal wound healing in vitro. Exp Eye Res. 2023 04; 229:109419. PMID: 36806671.
-
Cosert KM, Kim S, Jalilian I, Chang M, Gates BL, Pinkerton KE, Van Winkle LS, Raghunathan VK, Leonard BC, Thomasy SM. Metallic Engineered Nanomaterials and Ocular Toxicity: A Current Perspective. Pharmaceutics. 2022 May 03; 14(5). PMID: 35631569.
-
Fukuto A, Kim S, Kang J, Gates BL, Chang MW, Pinkerton KE, Van Winkle LS, Kiuchi Y, Murphy CJ, Leonard BC, Thomasy SM. Metal Oxide Engineered Nanomaterials Modulate Rabbit Corneal Fibroblast to Myofibroblast Transformation. Transl Vis Sci Technol. 2021 10 04; 10(12):23. PMID: 34661622.
-
Kim S, Gates BL, Chang M, Pinkerton KE, Van Winkle L, Murphy CJ, Leonard BC, Demokritou P, Thomasy SM. Transcorneal delivery of topically applied silver nanoparticles does not delay epithelial wound healing. NanoImpact. 2021 10; 24:100352. PMID: 35559825.
-
Wallace AD, Sasani TA, Swanier J, Gates BL, Greenland J, Pedersen BS, Varley KE, Quinlan AR. CaBagE: A Cas9-based Background Elimination strategy for targeted, long-read DNA sequencing. PLoS One. 2021; 16(4):e0241253. PMID: 33830997.
-
Balcioglu O, Heinz RE, Freeman DW, Gates BL, Hagos BM, Booker E, Mirzaei Mehrabad E, Diesen HT, Bhakta K, Ranganathan S, Kachi M, Leblanc M, Gray PC, Spike BT. CRIPTO antagonist ALK4L75A-Fc inhibits breast cancer cell plasticity and adaptation to stress. Breast Cancer Res. 2020 11 13; 22(1):125. PMID: 33187540.
-
Kim S, Gates B, Leonard BC, Gragg M, Pinkerton KE, Winkle LV, Murphy CJ, Pyrgiotakis G, Zhang Z, Demokritou P, Thomasy SM. Engineered metal oxide nanomaterials inhibit corneal epithelial wound healing in vitro and in vivo. NanoImpact. 2020 Jan; 17. PMID: 32154443.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2019 | 1 | | 2020 | 1 | | 2021 | 3 | | 2022 | 1 | | 2023 | 1 | | 2024 | 4 | | 2025 | 1 |
To return to the timeline, click here.
|
Gates's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|